These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19106397)

  • 1. Current status of percutaneous coronary intervention with drug-eluting stents in Asia.
    Park SJ; Kim YH
    Circulation; 2008 Dec; 118(25):2730-7. PubMed ID: 19106397
    [No Abstract]   [Full Text] [Related]  

  • 2. Bifurcation coronary artery disease: current techniques and future directions (part 2).
    Rizik DG; Klassen KJ; Hermiller JB
    J Invasive Cardiol; 2008 Mar; 20(3):135-41. PubMed ID: 18316830
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary stents: current status.
    Garg S; Serruys PW
    J Am Coll Cardiol; 2010 Aug; 56(10 Suppl):S1-42. PubMed ID: 20797502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal revascularization strategy for diabetic patients with multivessel coronary artery disease: the duel between old hero and young warrior.
    Celik T; Iyisoy A; Yuksel UC; Isik E
    Int J Cardiol; 2009 Jan; 131(2):269-70; author reply 271-2. PubMed ID: 17692947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter by Brugaletta et al. regarding article, "Interference of drug-eluting stents and endothelium-dependent coronary vasomotion: evidence for device-specific responses".
    Brugaletta S; Yuste VM; Sabaté M
    Circ Cardiovasc Interv; 2009 Apr; 2(2):e1; author reply e2. PubMed ID: 20031697
    [No Abstract]   [Full Text] [Related]  

  • 6. Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents.
    Bansal D; Sachdeva R; Mehta JL
    J Am Coll Cardiol; 2008 Mar; 51(9):970-1; author reply 971-2. PubMed ID: 18308169
    [No Abstract]   [Full Text] [Related]  

  • 7. Unique challenges of full metal jackets in the era of drug-eluting stents.
    Ho PC
    J Invasive Cardiol; 2009 Feb; 21(2):51-2. PubMed ID: 19182290
    [No Abstract]   [Full Text] [Related]  

  • 8. Inflation time and drug-eluting stent: the longer, the better..
    Bertrand OF
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):212-3. PubMed ID: 19156881
    [No Abstract]   [Full Text] [Related]  

  • 9. "Stick the landing," for optimal ostial placement of stents.
    Morrison DA
    Catheter Cardiovasc Interv; 2009 May; 73(6):769-70. PubMed ID: 19367630
    [No Abstract]   [Full Text] [Related]  

  • 10. Two-stent technique: a dead duck or alive and kicking?
    Belardi JA
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):321-2. PubMed ID: 19642180
    [No Abstract]   [Full Text] [Related]  

  • 11. Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.
    Daemen J; Simoons ML; Wijns W; Bagust A; Bos G; Bowen JM; Braunwald E; Camenzind E; Chevaliers B; DiMario C; Fajadeto J; Gitt A; Guagliumi G; Hillege HL; James S; Jüni P; Kastrati A; Kloth S; Kristensen SD; Krucoff M; Legrand V; Pfisterer M; Rothman M; Serruys PW; Silber S; Steg PG; Tariah I; Wallentin L; Windecker SW; Aimonetti A; Allocco D; Berenger M; Boam A; Calle JP; Campo G; Carlier S; de Schepper J; Di Bisceglie G; Dobbels H; Farb A; Ghislain JC; Hellbardt S; ten Hoedt R; Isaia C; de Jong P; Lekehal M; LeNarz L; Mhullain FN; Nagai H; Patteet A; Paunovic D; Potgieter A; Purdy I; Raveau-Landon C; Ternstrom S; Van Wuytswinkel J; Waliszewski M;
    EuroIntervention; 2009 Jan; 4(4):427-36. PubMed ID: 19284063
    [No Abstract]   [Full Text] [Related]  

  • 12. "Bailing out" side branches: technique trumps technology, round 1.
    Yang X; Popma JJ
    J Invasive Cardiol; 2009 Oct; 21(10):538. PubMed ID: 19805842
    [No Abstract]   [Full Text] [Related]  

  • 13. The need for a dedicated bifurcation stenting system.
    Kornowski R
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):641-2. PubMed ID: 19309702
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery restenosis: a paradigm of current treatment approaches.
    Kiernan TJ; Kiernan GD; Yan BD
    Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivessel disease in diabetics: does DES level the field?
    Hillegass W
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):881-2. PubMed ID: 19455651
    [No Abstract]   [Full Text] [Related]  

  • 17. On the loss of the phosphorylcholine-based DES coating on the abluminal surface of Endeavor stents.
    von Birgelen C; Basalus MW
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):158-9; author reply 160. PubMed ID: 20578103
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-eluting stents in patients with ESRD on dialysis: a small step forward.
    Ziada KM; Abdel-Latif A
    Am J Kidney Dis; 2009 Aug; 54(2):197-200. PubMed ID: 19619843
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous revascularization of the left main coronary artery bifurcation: still a bridge too far?
    Dubois CL
    Cardiology; 2009; 113(4):260-3. PubMed ID: 19246904
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary revascularisation following intracoronary brachytherapy.
    Sabaté M
    EuroIntervention; 2009 May; 5 Suppl D():D121-6. PubMed ID: 19736060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.